The Government Affairs Committee has been meeting virtually with each of the pharmaceutical companies who are providing new biosimilars to the Ontario population. We are outlining our expectations in terms of patient impact (convenience, no added costs), compassionate drug supply and general patient support. If you experience any issues with any of the new biosimilar medications, please let us know at email@example.com and we will reach out to the company and seek resolution. A list of currently available biosimilars and LU codes can be found here
Have you ever had a question that another specialist could answer for you? Don’t forget about eConsult, where you can request input from a listed eConsult specialist of your choice with a patient name and health card number. The time frame can be only hours and can save a patient referral that could take months. In addition, education including useful references often accompany the response. Information on eConsult can be found here.